Understanding OUR Cytokine-Based Immunotherapy Candidates Our Commitment extends to advancing a robust portfolio of programs targeted at growing the horizons of cytokine-based immunotherapy, especially for cancers where therapy alternatives remain limited. Use the links below to learn much more about our portfolio of cytokine-based immunotherapy candidates. Check out Our https://financefeeds.com/trading-technologies-promotes-justin-llewellyn-jones-to-ceo/